News

NF1 is a debilitating rare genetic disorder that causes tumours to form along nerves, often manifesting in childhood. It affects approximately one in 2,500 individuals worldwide and can lead to severe complications, including pain, disfigurement, and malignancies. Despite its impact, treatment options remain limited, with many patients facing invasive surgeries or therapies with severe side … Continued

Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, today announced the appointment of Jonathan Milner, Ph.D., as the new non-executive chairman of the board, effective immediately. This transition comes as current chairman and co-founder David Brown, Ph.D., begins a secondment to pursue academic research at Trinity College, Cambridge University. While pursuing his studies, … Continued